These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17570105)

  • 21. Suppression of choroidal neovascularization by dendritic cell vaccination targeting VEGFR2.
    Mochimaru H; Nagai N; Hasegawa G; Kudo-Saito C; Yaguchi T; Usui Y; Kurihara T; Koto T; Satofuka S; Shinoda H; Ozawa Y; Tsubota K; Kawakami Y; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4795-801. PubMed ID: 17898306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancing antitumor immunity: combining IL-12 with TGFbeta1 antagonism.
    Fan TM; Kranz DM; Roy EJ
    J Immunother; 2007; 30(5):479-89. PubMed ID: 17589288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cells.
    Poggi A; Zocchi MR
    Hum Immunol; 2008 Nov; 69(11):755-9. PubMed ID: 18817823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
    Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
    Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD8+ suppressor T cells resurrected.
    Kapp JA; Bucy RP
    Hum Immunol; 2008 Nov; 69(11):715-20. PubMed ID: 18817830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of tumor-specific CD8+ T Cells after intratumoral Ad5-TRAIL/CpG oligodeoxynucleotide combination therapy.
    VanOosten RL; Griffith TS
    Cancer Res; 2007 Dec; 67(24):11980-90. PubMed ID: 18089829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
    Mahic M; Henjum K; Yaqub S; Bjørnbeth BA; Torgersen KM; Taskén K; Aandahl EM
    Eur J Immunol; 2008 Mar; 38(3):640-6. PubMed ID: 18266270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical immunology of tuberculosis].
    Tsuyuguchi I
    Kekkaku; 1987 May; 62(5):253-64. PubMed ID: 3306085
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experience with therapy of experimental tuberculosis using immune lymphocytes].
    Tikhomirov VIa; Litvinov VI; Moroz AM; Markov AN; Il'ina IN
    Probl Tuberk; 1977 Jan; (1):69-71. PubMed ID: 834764
    [No Abstract]   [Full Text] [Related]  

  • 30. Corixa. Powering immunotherapeutics.
    Frederickson RM
    Chem Biol; 2002 Sep; 9(9):951-3. PubMed ID: 12323366
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of TGF beta in the pathogenesis of human tuberculosis.
    Toossi Z; Ellner JJ
    Clin Immunol Immunopathol; 1998 May; 87(2):107-14. PubMed ID: 9614924
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of phytohemagglutinin as an immunoregulator in the treatment of experimental tuberculosis].
    Chumak AA
    Probl Tuberk; 1983 Mar; (3):63-8. PubMed ID: 6856612
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunotherapy for tuberculosis].
    Ma Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Aug; 32(8):565-7. PubMed ID: 19958671
    [No Abstract]   [Full Text] [Related]  

  • 34. [Progress of immune therapy for tuberculosis].
    Zhao JQ; Guo SL
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Dec; 34(12):931-4. PubMed ID: 22333508
    [No Abstract]   [Full Text] [Related]  

  • 35. [Tuberculosis caused by hazards of civilization and the possibility of treating it with climate therapy].
    TRAUNER L
    Arch Phys Ther (Leipz); 1957; 9(3):244-50. PubMed ID: 13445152
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experimental tuberculosis in mice].
    Someya S
    Nihon Saikingaku Zasshi; 1984 Jul; 39(4):745-8. PubMed ID: 6502933
    [No Abstract]   [Full Text] [Related]  

  • 37. Tuberculosis: latency and reactivation.
    Flynn JL; Chan J
    Infect Immun; 2001 Jul; 69(7):4195-201. PubMed ID: 11401954
    [No Abstract]   [Full Text] [Related]  

  • 38. Corixa: integrating immunotherapeutics.
    Frederickson RM
    Mol Ther; 2003 Apr; 7(4):431. PubMed ID: 12731543
    [No Abstract]   [Full Text] [Related]  

  • 39. [Non-specific and specific hyperergy in tuberculosis; experimental studies].
    PACKALEN T
    Nord Med; 1955 Mar; 53(11):427. PubMed ID: 14370555
    [No Abstract]   [Full Text] [Related]  

  • 40. Treating tuberculosis in a military hospital.
    BURKE RM; WIER JA
    U S Armed Forces Med J; 1957 Jul; 8(7):963-71. PubMed ID: 13443059
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.